Tackling Diabetes From Every Angle

September, 2021

Physicians, geneticists, chemists, and other researchers in Broad’s Diabetes Research Group are working together and taking multiple approaches to improve treatment for patients with diabetes.


ADA 2019 – Diabetes Research Across the Spectrum

June, 2019

Jose C Florez joins us at the ADA annual meeting 2019 to discuss his presentation on diabetes research across the spectrum – from cell-based to clinical translation.

Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA

1) What are the major obstacles to achieving personalised medicine in diabetes?
2) What is the role of epigenetic changes in the progression of type 1 and type 2 diabetes?
3) How will increased understanding of these changes affect the management of patients of diabetes?
4) What further research is needed to elucidate the genetic architecture of type 2 diabetes?
5) What recent advances in translational research in diabetes have excited you most?

Highlights of the ADA 79th Scientific Sessions

June, 2019

We take a look at some of the highlights of the last two days of the ADA 79th Scientific Sessions, and who better to take a look at the program with us than ADA Scientific Sessions planning committee chair Dr Jose Florez.

Massive NIH–industry project opens portals to target validation

February, 2019

Five years in, the US$360 million Accelerating Medicines Partnership is yielding tools to speed up drug discovery for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease.

DNA analysis identifies five subtypes of type two diabetes

September, 2018

The genomic study brings us closer to precision medicine for type 2 diabetes

September, 2018

Type 2 diabetes: Five genetic ‘clusters’ may explain evolution

La Medicina Personalizada para la diabetes tipo 2, cada vez más cerca

September, 2018

Más cerca de la medicina de precisión para la diabetes tipo 2

Una nueva clasificación de la diabetes tipo 2 facilitará la medicina ‘a la carta’

September, 2018